Status:
TERMINATED
Hydroxychloroquine vs Nitazoxanide in Patients With COVID-19
Lead Sponsor:
Hugo Mendieta Zeron
Conditions:
Coronavirus Infection
Eligibility:
All Genders
5+ years
Phase:
PHASE4
Brief Summary
Coronaviruses (CoV) are positive-sense single-stranded RNA viruses that infect a wide range of hosts producing diseases ranging from the common cold to serious / fatal events. Nitazoxanide (NTZx) is a...
Detailed Description
Introduction The current pandemic caused by the SARS-COV2 coronavirus (COVID-19) is life-threatening and is challenging the world's best health systems. Accelerated spread of this pandemia led physici...
Eligibility Criteria
Inclusion
- COVID-19 positive patients
- Treated at the Health Institute of the State of Mexico (ISEM).
- With risk factors to get complicated: age more than 60 years old, diabetes mellitus or obesity grade II or more.
Exclusion
- Patients who have inherent contraindications to each drug.
Key Trial Info
Start Date :
April 6 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2020
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT04341493
Start Date
April 6 2020
End Date
December 30 2020
Last Update
April 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Materno-Perinatal Hospital "Mónica Pretelini"
Toluca, Mexico, 50130